// App-Quantinova.ai

: CHARACTERIZATION OF A DUX4-IGH INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Mara Salome'

Principal Investigators

  • Claudia Caronni

  • Valeria Runfola

  • Roberto Giambruno

  • Daniele Campolungo

  • Chiara Ghirardi

  • Davide Gabellini

Medical Centers

  • Division of Genetic and Cell Biology, DiBiT- San Raffaele Scientific Institute, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved